Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PRECISION BIOSCIENCES INCDTIL · Entity 6284 | Chief Financial Officer | June 15, 2020 | June 17, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PRECISION BIOSCIENCES INC
Report date June 15, 2020 · Filed June 17, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 144,401 |
Reported balance
After 2020-06-15 transaction · row 1
1 source rowRow 1 · 2020-06-15 · Exercise / conversion · Acquired 8,783 · Balance 144,401 |
| Employee Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.20 · Expires 2026-08-10 | Direct | 8,785 |
Reported balance
After 2020-06-15 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2020-06-15 · Exercise / conversion · Disposed 8,783 · Balance 8,785 F1: The option vested as to 25% of the underlying shares on August 11, 2017 and vests in equal installments at the end of each successive three month period over the 36 months following such date. |
Filing footnotes · ownership attribution and instrument terms
F1: The option vested as to 25% of the underlying shares on August 11, 2017 and vests in equal installments at the end of each successive three month period over the 36 months following such date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 15, 2020 Filed Jun 17, 2020 20:00 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 8,783 | $0.00 Strike: $1.20 | $0.00 |
DisclosureSEC source: 0001209191-20-037218 · doc4.xml · derivative · entry 2 ANSARI ABID · CIK 0001770149 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,785 Underlying: Common Stock · 8,783 shares Expires 2026-08-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested as to 25% of the underlying shares on August 11, 2017 and vests in equal installments at the end of each successive three month period over the 36 months following such date. Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 20:00 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionCommon Stock | 8,783 | $1.20 | $10,539.60 |
DisclosureSEC source: 0001209191-20-037218 · doc4.xml · nonDerivative · entry 1 ANSARI ABID · CIK 0001770149 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,401 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 21:00 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | GrantEmployee Stock Option (Right to Buy) · Derivative | 112,141 | $0.00 Strike: $8.21 | $0.00 |
DisclosureSEC source: 0001209191-20-035570 · doc4.xml · derivative · entry 1 ANSARI ABID · CIK 0001770149 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,141 Underlying: Common Stock · 112,141 shares Expires 2030-06-07 F1 · derivative.exercise_date: The option vests as to 25% of the underlying shares on April 1, 2021 and vests in equal installments at the end of each successive three-month period over the 36 months following such date. Read SEC document |
| May 15, 2020 Filed May 19, 2020 11:17 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 878 | $0.00 Strike: $1.18 | $0.00 |
DisclosureSEC source: 0001209191-20-030319 · doc4.xml · derivative · entry 4 ANSARI ABID · CIK 0001770149 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,514 Underlying: Common Stock · 878 shares Expires 2027-03-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested as to 25% of the underlying shares on March 24, 2018 and vests in equal installments at the end of each successive three month period over the 36 months following such date. Read SEC document |
| May 15, 2020 Filed May 19, 2020 11:17 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 8,783 | $0.00 Strike: $1.20 | $0.00 |
DisclosureSEC source: 0001209191-20-030319 · doc4.xml · derivative · entry 3 ANSARI ABID · CIK 0001770149 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,568 Underlying: Common Stock · 8,783 shares Expires 2026-08-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested as to 25% of the underlying shares on August 11, 2017 and vests in equal installments at the end of each successive three month period over the 36 months following such date. Read SEC document |
| May 15, 2020 Filed May 19, 2020 11:17 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionCommon Stock | 878 | $1.18 | $1,036.04 |
DisclosureSEC source: 0001209191-20-030319 · doc4.xml · nonDerivative · entry 2 ANSARI ABID · CIK 0001770149 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,618 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 2,112 additional shares acquired under the Company's 2019 Employee Stock Purchase Plan since the Reporting Person's ownership report filed on January 8, 2020. Read SEC document |
| May 15, 2020 Filed May 19, 2020 11:17 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionCommon Stock | 8,783 | $1.20 | $10,539.60 |
DisclosureSEC source: 0001209191-20-030319 · doc4.xml · nonDerivative · entry 1 ANSARI ABID · CIK 0001770149 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,740 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 2,112 additional shares acquired under the Company's 2019 Employee Stock Purchase Plan since the Reporting Person's ownership report filed on January 8, 2020. Read SEC document |
| January 06, 2020 Filed Jan 8, 2020 13:23 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,634 | $0.00 Strike: $1.18 | $0.00 |
DisclosureSEC source: 0001209191-20-002445 · doc4.xml · derivative · entry 4 ANSARI ABID · CIK 0001770149 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,392 Underlying: Common Stock · 2,634 shares Expires 2027-03-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested as to 25% of the underlying shares on March 24, 2018 and vests in equal installments at the end of each successive three-month period over the 36 months following such date. Read SEC document |
| January 06, 2020 Filed Jan 8, 2020 13:23 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 17,566 | $0.00 Strike: $1.20 | $0.00 |
DisclosureSEC source: 0001209191-20-002445 · doc4.xml · derivative · entry 3 ANSARI ABID · CIK 0001770149 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,351 Underlying: Common Stock · 17,566 shares Expires 2026-08-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested as to 25% of the underlying shares on August 11, 2017 and vests in equal installments at the end of each successive three-month period over the 36 months following such date. Read SEC document |
| January 06, 2020 Filed Jan 8, 2020 13:23 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionCommon Stock | 2,634 | $1.18 | $3,108.12 |
DisclosureSEC source: 0001209191-20-002445 · doc4.xml · nonDerivative · entry 2 ANSARI ABID · CIK 0001770149 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,845 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 06, 2020 Filed Jan 8, 2020 13:23 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionCommon Stock | 17,566 | $1.20 | $21,079.20 |
DisclosureSEC source: 0001209191-20-002445 · doc4.xml · nonDerivative · entry 1 ANSARI ABID · CIK 0001770149 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,211 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 23, 2019 Filed Sep 25, 2019 20:24 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | GrantEmployee Stock Option (Right to Buy) · Derivative | 52,818 | $0.00 Strike: $9.46 | $0.00 |
DisclosureSEC source: 0001209191-19-050701 · doc4.xml · derivative · entry 1 ANSARI ABID · CIK 0001770149 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,818 Underlying: Common Stock · 52,818 shares Expires 2029-09-22 F1 · derivative.exercise_date: The option vests as to 25% of the underlying shares on April 1, 2020 and vests in equal installments at the end of each successive three-month period over the 36 months following such date. Read SEC document |
| June 10, 2019 Filed Jun 12, 2019 14:27 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 7,027 | $0.00 Strike: $1.18 | $0.00 |
DisclosureSEC source: 0001209191-19-036287 · doc4.xml · derivative · entry 4 ANSARI ABID · CIK 0001770149 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,026 Underlying: Common Stock · 7,027 shares Expires 2027-03-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests as to 25% of the underlying shares on March 24, 2018 and vests in equal installments at the end of each successive three-month period over the following 36 months. Read SEC document |
| June 10, 2019 Filed Jun 12, 2019 14:27 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 96,618 | $0.00 Strike: $1.20 | $0.00 |
DisclosureSEC source: 0001209191-19-036287 · doc4.xml · derivative · entry 3 ANSARI ABID · CIK 0001770149 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,917 Underlying: Common Stock · 96,618 shares Expires 2026-08-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vests as to 25% of the underlying shares on August 11, 2017 and vests in equal installments at the end of each successive three-month period over the following 36 months. Read SEC document |
| June 10, 2019 Filed Jun 12, 2019 14:27 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionCommon Stock | 7,027 | $1.18 | $8,291.86 |
DisclosureSEC source: 0001209191-19-036287 · doc4.xml · nonDerivative · entry 2 ANSARI ABID · CIK 0001770149 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,645 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 10, 2019 Filed Jun 12, 2019 14:27 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionCommon Stock | 96,618 | $1.20 | $115,941.60 |
DisclosureSEC source: 0001209191-19-036287 · doc4.xml · nonDerivative · entry 1 ANSARI ABID · CIK 0001770149 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,618 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.